1 / 60

Global Measles and Rubella Update February 2019

Stay informed with the latest measles and rubella data from Global Health Organizations. Explore reported cases by WHO Regions and monthly trends. Includes incidence rates, country profiles, and data accuracy disclaimers.

bgardner
Download Presentation

Global Measles and Rubella Update February 2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Measles and Rubella Update February 2019

  2. Measles

  3. Number of Reported Measles Cases by WHO Regions Notes: Based on data received 2019-02 - This is surveillance data, hence for the last month, the data may be incomplete. * Member States Reporting / Total Member States in Region

  4. Measles case distribution by month and WHO Region (2015-2019) 40000 WPR SEAR EUR 35000 EMR AMR AFR 30000 25000 Measles cases (Lab+Epi+Clinical) 20000 15000 10000 5000 0 2015-01 2015-02 2015-03 2015-04 2015-05 2015-06 2015-07 2015-08 2015-09 2015-10 2015-11 2015-12 2016-01 2016-02 2016-03 2016-04 2016-05 2016-06 2016-07 2016-08 2016-09 2016-10 2016-11 2016-12 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Month of onset Notes: Based on data received 2019-02 - Data Source: IVB Database - This is surveillance data, hence for the last month(s), the data may be incomplete.

  5. Measles Incidence Rate per Million (12M period) Notes: Based on data received 2019-02 and covering the period between 2018-01 and 2018-12 - Incidence: Number of cases / population* * 100,000 - * World population prospects, 2017 revision - ** Countries with the highest number of cases for the period - *** Countries with the highest incidence rates (excluding those already listed in the table above)

  6. Number of Reported Measles Cases (6M period) Notes: Based on data received 2019-02 - Surveillance data from 2018-07 to 2018-12 - * Countries with highest number of cases for the period

  7. Measles case distribution (AFR), 2015-2019 Uganda Ghana Ethiopia Others Equatorial Guinea Nigeria 8000 Niger DR Congo Madagascar Cameroon Liberia 6000 Number of measles cases 4000 2000 0 2015-01 2015-02 2015-03 2015-04 2015-05 2015-06 2015-07 2015-08 2015-09 2015-10 2015-11 2015-12 2016-01 2016-02 2016-03 2016-04 2016-05 2016-06 2016-07 2016-08 2016-09 2016-10 2016-11 2016-12 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 Month of onset Notes: Based on data received 2019-02 - Data Source: IVB Database DRC has experienced a nationwide epidemic that has affected all Provinces, however, only a small proportion of the measles cases in the IDSR aggregate reporting system are reflected in the case based data. As of 27 May 2013, South Sudan has reassigned to the Africa region (AFR) from the Eastern Mediterranean region (EMR). For data presentation and statistical purposes, South Sudan data is presented in AFR for all the years.

  8. Disclaimer • This document contains data provided to WHO by member states. Note that some member states only provide aggregate data to WHO, and for these, we are unable to generate a country profile. Some member states report all cases at one time point for the entire year, and thus epidemiologic curves generated are not accurate and a reporting artifact. For some countries, cases are reported by age category, not by exact age in months and/or years. Thus, age distribution/incidence is approximate. Cases classified as pending by countries are classified at WHO as clinically compatible at this time, and thus numbers might different between data shown here and provided by the member state or WHO country/regional offices. • *UN population data is used as the denominator for calculating incidence.

  9. Measles cases: Benin 200 Number of cases 100 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset Benin age distribution, vaccination status, and incidence, 2018-01 to 2018-12 600 400 361.3 500 300 400 259.4 Incidence rate per 1,000,000 Number of cases 300 200 128 200 100 36.1 100 16.1 7.9 3.5 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  10. Measles cases: Democratic Republic of the Congo Sub-national (6-59 M) 1500 Cov: 103.5% 1000 Number of cases 500 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset National SIA Sub-national SIA Democratic Republic of the Congo age distribution, vaccination status, and incidence, 2018-01 to 2018-12 4000 294.5 300 254.5 200 Incidence rate per 1,000,000 Number of cases 2000 101.2 100 17.3 6.7 3.5 0.9 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  11. Measles cases: Ethiopia Sub-national (9 M-14 Y) Sub-national (6-179 M) Cov: 96.3% Cov: 98% 600 400 Number of cases 200 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset National SIA Sub-national SIA Ethiopia age distribution, vaccination status, and incidence, 2018-01 to 2018-12 400 23.8 23.7 20 300 16.8 13.4 Incidence rate per 1,000,000 Number of cases 200 9.7 10 8.3 100 1.1 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  12. Measles cases: Guinea Sub-national (6-10 Y) Sub-national (6-59 M) Sub-national (6-10 Y) Cov: 104% Cov: 104% Cov: 97% 300 200 Number of cases 100 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset National SIA Sub-national SIA Guinea age distribution, vaccination status, and incidence, 2018-01 to 2018-12 197.8 200 300 184.4 150 200 Incidence rate per 1,000,000 Number of cases 100 48.6 100 50 10.3 7.6 4.9 0.4 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  13. Measles cases: Liberia National (9-59 M) Cov: 97% 600 400 Number of cases 200 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset National SIA Sub-national SIA Liberia age distribution, vaccination status, and incidence, 2018-01 to 2018-12 1200 1069.4 1001.1 1000 600 800 Incidence rate per 1,000,000 400 Number of cases 600 527.5 339.9 400 200 200 74.5 10.8 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  14. Measles cases: Mali 400 300 Number of cases 200 100 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset Mali age distribution, vaccination status, and incidence, 2018-01 to 2018-12 200 500 167.2 400 150 127.3 300 Incidence rate per 1,000,000 Number of cases 100 64.2 200 50 28.4 100 21 11.6 1.5 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  15. Measles cases: Niger 400 300 Number of cases 200 100 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset Niger age distribution, vaccination status, and incidence, 2018-01 to 2018-12 800 204.3 200 173.3 600 150 Incidence rate per 1,000,000 Number of cases 400 93.9 100 45.9 200 50 31.5 23.7 4.1 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  16. Measles cases: Nigeria National (9-59 M) National (9-59 M) Cov: 107% Cov: 106% 3000 2000 Number of cases 1000 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset National SIA Sub-national SIA Nigeria age distribution, vaccination status, and incidence, 2018-01 to 2018-12 4000 150 137.4 119.7 100 Incidence rate per 1,000,000 Number of cases 2000 63.4 50 23.4 6.9 4.6 2.3 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  17. Measles cases: Uganda 600 500 400 Number of cases 300 200 100 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset Uganda age distribution, vaccination status, and incidence, 2018-01 to 2018-12 1400 250 218.7 1200 203 200 1000 150 800 Incidence rate per 1,000,000 Number of cases 104.5 600 100 400 51.3 50 20.6 200 5.3 2.7 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  18. Measles case distribution (AMR), 2015-2019 6500 Venezuela (Bolivarian Republic of) Chile Canada USA 6000 Brazil Peru Argentina Others 5500 Antigua and Barbuda Mexico 5000 Colombia 4500 4000 3500 Number of measles cases 3000 2500 2000 1500 1000 500 0 2015-01 2015-02 2015-03 2015-04 2015-05 2015-06 2015-07 2015-08 2015-09 2015-10 2015-11 2015-12 2016-01 2016-02 2016-03 2016-04 2016-05 2016-06 2016-07 2016-08 2016-09 2016-10 2016-11 2016-12 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Month of onset Notes: Based on data received 2019-02 - Data Source: IVB Database

  19. Disclaimer • This document contains data provided to WHO by member states. Note that some member states only provide aggregate data to WHO, and for these, we are unable to generate a country profile. Some member states report all cases at one time point for the entire year, and thus epidemiologic curves generated are not accurate and a reporting artifact. For some countries, cases are reported by age category, not by exact age in months and/or years. Thus, age distribution/incidence is approximate. Cases classified as pending by countries are classified at WHO as clinically compatible at this time, and thus numbers might different between data shown here and provided by the member state or WHO country/regional offices. • *UN population data is used as the denominator for calculating incidence.

  20. Measles cases: Venezuela (Bolivarian Republic of) Sub-national (6 M-15 Y) 6000 4000 Number of cases 2000 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset National SIA Sub-national SIA Venezuela (Bolivarian Republic of) age distribution, vaccination status, and incidence, 2018-01 to 2018-12 1500 1646.2 1500 1000 Incidence rate per 1,000,000 1000 Number of cases 571.3 500 500 160.1 112.2 34.6 13.2 7.6 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  21. Measles case distribution (EMR), 2015-2018 10500 Others Yemen 10000 Libya United Arab Emirates 9500 Syrian Arab Republic Iraq 9000 Egypt Sudan 8500 Afghanistan Saudi Arabia 8000 Pakistan 7500 7000 6500 6000 5500 Number of measles cases 5000 4500 4000 3500 3000 2500 2000 1500 1000 500 0 2015-01 2015-02 2015-03 2015-04 2015-05 2015-06 2015-07 2015-08 2015-09 2015-10 2015-11 2015-12 2016-01 2016-02 2016-03 2016-04 2016-05 2016-06 2016-07 2016-08 2016-09 2016-10 2016-11 2016-12 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 Month of onset Notes: Based on data received 2019-02 - Data Source: IVB Database

  22. Disclaimer • This document contains data provided to WHO by member states. Note that some member states only provide aggregate data to WHO, and for these, we are unable to generate a country profile. Some member states report all cases at one time point for the entire year, and thus epidemiologic curves generated are not accurate and a reporting artifact. For some countries, cases are reported by age category, not by exact age in months and/or years. Thus, age distribution/incidence is approximate. Cases classified as pending by countries are classified at WHO as clinically compatible at this time, and thus numbers might different between data shown here and provided by the member state or WHO country/regional offices. • *UN population data is used as the denominator for calculating incidence.

  23. Measles cases: Pakistan Sub-national (9-119 M) Sub-national (6-59 M) 8000 Cov: 87% Cov: 99% 6000 Number of cases 4000 2000 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset National SIA Sub-national SIA Pakistan age distribution, vaccination status, and incidence, 2018-01 to 2018-12 22000 20000 1630.1 18000 1500 16000 14000 12000 907 Incidence rate per 1,000,000 1000 Number of cases 10000 8000 500 6000 252.2 4000 49.4 7.1 2000 2.8 0.6 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  24. Measles cases: Syrian Arab Republic 200 Number of cases 100 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset Syrian Arab Republic age distribution, vaccination status, and incidence, 2018-01 to 2018-12 150 127.8 150 100 85.7 100 Incidence rate per 1,000,000 Number of cases 50 50 23.9 13.7 5.1 3.4 0.7 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  25. Measles case distribution (EUR), 2015-2018 13000 Ukraine Kazakhstan Italy Serbia 12000 Russian Federation Greece Germany Romania 11000 Others France Kyrgyzstan 10000 9000 8000 7000 Number of measles cases 6000 5000 4000 3000 2000 1000 0 2015-01 2015-02 2015-03 2015-04 2015-05 2015-06 2015-07 2015-08 2015-09 2015-10 2015-11 2015-12 2016-01 2016-02 2016-03 2016-04 2016-05 2016-06 2016-07 2016-08 2016-09 2016-10 2016-11 2016-12 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 Month of onset Notes: Based on data received 2019-02 - Data Source: IVB Database

  26. Disclaimer • This document contains data provided to WHO by member states. Note that some member states only provide aggregate data to WHO, and for these, we are unable to generate a country profile. Some member states report all cases at one time point for the entire year, and thus epidemiologic curves generated are not accurate and a reporting artifact. For some countries, cases are reported by age category, not by exact age in months and/or years. Thus, age distribution/incidence is approximate. Cases classified as pending by countries are classified at WHO as clinically compatible at this time, and thus numbers might different between data shown here and provided by the member state or WHO country/regional offices. • *UN population data is used as the denominator for calculating incidence.

  27. Measles cases: France 800 600 Number of cases 400 200 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset France age distribution, vaccination status, and incidence, 2018-01 to 2018-12 400 362.9 600 300 400 Incidence rate per 1,000,000 195.1 Number of cases 200 87.5 200 79.3 100 72.7 52.5 5 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  28. Measles cases: Georgia 600 500 400 Number of cases 300 200 100 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset Georgia age distribution, vaccination status, and incidence, 2018-01 to 2018-12 800 4107 4000 600 3000 Incidence rate per 1,000,000 Number of cases 400 2000 1399.9 834.9 797.3 790.4 1000 200 669.5 104.5 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  29. Measles cases: Greece 600 500 400 Number of cases 300 200 100 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset Greece age distribution, vaccination status, and incidence, 2018-01 to 2018-12 600 3000 2546 500 400 2000 Incidence rate per 1,000,000 Number of cases 300 1124.2 1000 200 671.9 404.4 100 210.4 187.4 40.8 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  30. Measles cases: Italy 1200 1000 800 Number of cases 600 400 200 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset Italy age distribution, vaccination status, and incidence, 2018-01 to 2018-12 1200 320 1000 300 800 200 Incidence rate per 1,000,000 Number of cases 600 157 96.5 400 87.1 100 35.9 31.7 200 9.5 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  31. Measles cases: Russian Federation 800 600 Number of cases 400 200 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset Russian Federation age distribution, vaccination status, and incidence, 2018-01 to 2018-12 115.5 120 600 100 78 80 400 Incidence rate per 1,000,000 Number of cases 60 35.3 40 200 18 17.9 14.6 20 4 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  32. Measles cases: Serbia 1500 1000 Number of cases 500 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset Serbia age distribution, vaccination status, and incidence, 2018-01 to 2018-12 5000 4576.2 4000 2000 3000 Incidence rate per 1,000,000 Number of cases 1934.9 2000 1000 598.4 400.4 399 262.2 210.2 0 0 5-9 years 10-14 years 15-19 years 20-29 years 30+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  33. Measles cases: Ukraine National (6-9 Y) National (1-9 Y) Cov: 57% Cov: 67% 10000 Number of cases 5000 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset National SIA Sub-national SIA Ukraine age distribution, vaccination status, and incidence, 2018-01 to 2018-12 12000 6000 5551.3 10000 5000 4538.9 4237.5 4110.7 4000 8000 Incidence rate per 1,000,000 Number of cases 3000 6000 2000 4000 1289.8 823.9 1000 2000 384.3 0 0 5-9 years 10-14 years 15-19 years 20-29 years 30+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  34. Measles case distribution (SEAR (excl. India)), 2015-2019 3500 Maldives Timor-Leste Thailand Indonesia Sri Lanka DPR Korea 3000 Nepal Bhutan Bangladesh Myanmar 2500 2000 Number of measles cases 1500 1000 500 0 2015-01 2015-02 2015-03 2015-04 2015-05 2015-06 2015-07 2015-08 2015-09 2015-10 2015-11 2015-12 2016-01 2016-02 2016-03 2016-04 2016-05 2016-06 2016-07 2016-08 2016-09 2016-10 2016-11 2016-12 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 Month of onset Notes: Based on data received 2019-02 - Data Source: IVB Database

  35. Disclaimer • This document contains data provided to WHO by member states. Note that some member states only provide aggregate data to WHO, and for these, we are unable to generate a country profile. Some member states report all cases at one time point for the entire year, and thus epidemiologic curves generated are not accurate and a reporting artifact. For some countries, cases are reported by age category, not by exact age in months and/or years. Thus, age distribution/incidence is approximate. Cases classified as pending by countries are classified at WHO as clinically compatible at this time, and thus numbers might different between data shown here and provided by the member state or WHO country/regional offices. • *UN population data is used as the denominator for calculating incidence.

  36. Measles cases: Indonesia Sub-national (9 M-15 Y) Rollover-Nat (9 M-15 Y) 6000 Cov: 101% Cov: 73% 4000 Number of cases 2000 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset National SIA Sub-national SIA Indonesia age distribution, vaccination status, and incidence, 2018-01 to 2018-12 400 38 40 300 Incidence rate per 1,000,000 Number of cases 200 20 17.1 15 9.2 100 5.3 1.3 0.2 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  37. Measles case distribution (SEAR, India), 2015-2018 India 15000 10000 Number of measles cases 5000 0 2015-01 2015-02 2015-03 2015-04 2015-05 2015-06 2015-07 2015-08 2015-09 2015-10 2015-11 2015-12 2016-01 2016-02 2016-03 2016-04 2016-05 2016-06 2016-07 2016-08 2016-09 2016-10 2016-11 2016-12 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 Month of onset Notes: Based on data received 2019-02 - Data Source: IVB Database

  38. Disclaimer • This document contains data provided to WHO by member states. Note that some member states only provide aggregate data to WHO, and for these, we are unable to generate a country profile. Some member states report all cases at one time point for the entire year, and thus epidemiologic curves generated are not accurate and a reporting artifact. For some countries, cases are reported by age category, not by exact age in months and/or years. Thus, age distribution/incidence is approximate. Cases classified as pending by countries are classified at WHO as clinically compatible at this time, and thus numbers might different between data shown here and provided by the member state or WHO country/regional offices. • *UN population data is used as the denominator for calculating incidence.

  39. Measles cases: India Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Rollover-Nat (9 M-15 Y) Cov: 100.9% Cov: 106.9% Cov: 101.6% Cov: 101.9% Cov: 97.1% Cov: 96.7% Cov: 101.4% Cov: 84.8% Cov: 98.3% Cov: 101.1% Cov: 96.9% Cov: 93.98% Cov: 100% Cov: 99% Cov: 95.98% Cov: 96.7% Cov: 96% Cov: 95.1% Cov: 99.6% Cov: 93.5% Cov: 97.8% 30000 20000 Number of cases 10000 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset National SIA Sub-national SIA India age distribution, vaccination status, and incidence, 2018-01 to 2018-12 120 10000 101.4 100 84.2 8000 80 71 6000 Incidence rate per 1,000,000 Number of cases 60 4000 40 20.1 20 2000 4.7 1.5 0.3 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  40. Measles case distribution (WPR), 2015-2019 18000 Malaysia Viet Nam Lao People's Democratic Republic Singapore Philippines Japan 16000 Others China New Zealand Australia 14000 Mongolia 12000 10000 Number of measles cases 8000 6000 4000 2000 0 2015-01 2015-02 2015-03 2015-04 2015-05 2015-06 2015-07 2015-08 2015-09 2015-10 2015-11 2015-12 2016-01 2016-02 2016-03 2016-04 2016-05 2016-06 2016-07 2016-08 2016-09 2016-10 2016-11 2016-12 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 Month of onset Notes: Based on data received 2019-02 - Data Source: IVB Database

  41. Disclaimer • This document contains data provided to WHO by member states. Note that some member states only provide aggregate data to WHO, and for these, we are unable to generate a country profile. Some member states report all cases at one time point for the entire year, and thus epidemiologic curves generated are not accurate and a reporting artifact. For some countries, cases are reported by age category, not by exact age in months and/or years. Thus, age distribution/incidence is approximate. Cases classified as pending by countries are classified at WHO as clinically compatible at this time, and thus numbers might different between data shown here and provided by the member state or WHO country/regional offices. • *UN population data is used as the denominator for calculating incidence.

  42. Measles cases: Philippines 3000 2000 Number of cases 1000 0 Discarded 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Clinical Epi Lab Month of onset Philippines age distribution, vaccination status, and incidence, 2018-01 to 2018-12 3000 2766.5 8000 6000 2000 Incidence rate per 1,000,000 Number of cases 4000 844.4 1000 2000 142.3 126.6 70.4 69.9 8.6 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  43. Distribution of measles genotypes (last 12 months) Notes: Data Source: MeaNS database (Genotypes) and IVB Database (Incidence) as of 2019-02-11 and covering the period 2018-01-01 to 2018-12-31 - Pie charts proportional to the number of sequenced viruses

  44. Rubella

  45. Number of Reported Rubella Cases by WHO Regions Notes: Based on data received 2019-02 - This is surveillance data, hence for the last month, the data may be incomplete. * Member States Reporting / Total Member States in Region

  46. Rubella Case Distribution by Month and WHO Region (2015-2019) WPR 5500 SEAR EUR 5000 EMR AMR 4500 AFR 4000 3500 3000 Rubella cases (Lab+Epi+Clinical) 2500 2000 1500 1000 500 0 2015-01 2015-02 2015-03 2015-04 2015-05 2015-06 2015-07 2015-08 2015-09 2015-10 2015-11 2015-12 2016-01 2016-02 2016-03 2016-04 2016-05 2016-06 2016-07 2016-08 2016-09 2016-10 2016-11 2016-12 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 Month of onset Notes: Based on data received 2019-02 - Data Source: IVB Database - This is surveillance data, hence for the last month(s), the data may be incomplete.

  47. Rubella cases: AFR AFR Rubella Case Distribution (February 2017-January 2019) 600 400 (IgM+ only) Number of cases 200 0 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Month of onset Introduced <5 years ago Introduced >=5 years ago Not introduced in EPI (after 2013) (2013 and before) AFR Age distribution of Rubella IgM+ cases by vaccine introduction status in the National EPI Programme (February 2018-January 2019) 500 400 300 (IgM+ only) Number of cases 200 100 0 0 3 6 8 9 2 5 1 4 7 10 13 16 18 19 20 23 25 26 28 29 30 31 32 33 34 35 36 37 38 39 40 43 46 15 24 27 42 45 12 21 22 14 17 41 11 44 Age at onset (in years) Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017 Notes: Based on data received 2019-02 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31 Dec 2016.

  48. Rubella cases: Algeria Cov: 45% 20 Number of cases 10 0 Clinical 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Epi Lab Month of onset National SIA Sub-national SIA Algeria age distribution, vaccination status, and incidence, 2018-01 to 2018-12 3 3 2.6 10 2 Incidence rate per 1,000,000 Number of cases 1.1 5 1 0.6 0 0 0 0 0 5-9 years 10-14 years 15-24 years 25-39 years 40+ years <1 year 1-4 years Age at onset Unknown 0 doses 1 dose 2+ doses

  49. Rubella cases: EMR EMR Rubella Case Distribution (February 2017-January 2019) 200 (lab + epi-linked + clinical) Number of cases 100 0 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Month of onset Introduced <5 years ago Introduced >=5 years ago Not introduced in EPI (after 2013) (2013 and before) EMR Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (February 2018-January 2019) 200 (lab + epi-linked + clinical) Number of cases 100 0 0 3 6 8 9 2 5 1 4 7 10 13 16 18 19 20 23 25 26 28 29 30 31 32 33 34 35 36 37 38 39 40 43 46 15 24 27 42 45 12 21 22 14 17 41 11 44 Age at onset (in years) Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017 Notes: Based on data received 2019-02 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31 Dec 2016.

  50. Rubella cases: EUR EUR Rubella Case Distribution (February 2017-January 2019) 100 80 60 (lab + epi-linked + clinical) Number of cases 40 20 0 2017-01 2017-02 2017-03 2017-04 2017-05 2017-06 2017-07 2017-08 2017-09 2017-10 2017-11 2017-12 2018-01 2018-02 2018-03 2018-04 2018-05 2018-06 2018-07 2018-08 2018-09 2018-10 2018-11 2018-12 2019-01 2019-02 Month of onset Introduced <5 years ago Introduced >=5 years ago Not introduced in EPI (after 2013) (2013 and before) EUR Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (February 2018-January 2019) 200 (lab + epi-linked + clinical) Number of cases 100 0 0 3 6 8 9 2 5 1 4 7 10 13 16 18 19 20 23 25 26 28 29 30 31 32 33 34 35 36 37 38 39 40 43 46 15 24 27 42 45 12 21 22 14 17 41 11 44 Age at onset (in years) Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017 Notes: Based on data received 2019-02 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31 Dec 2016. Spikes in age-distribution curve are an artifact of reporting by age bands ( 0=<1 yrs, 2=1-4 yrs, 7=5-9 yrs, 12=10-14 yrs, 17=15-19 yrs, 25=20-29 yrs, 45=30+yrs) instead of by age from some member states.

More Related